Annals of Clinical Microbiology and Antimicrobials Open Access Etiology and Antibiotic Resistance Patterns of Community-acquired Urinary Tract Infections in J N M C Hospital Aligarh, India

BackgroundUrinary tract infections (UTIs) remain the common infections diagnosed in outpatients as well as hospitalized patients. Current knowledge on antimicrobial susceptibility pattern is essential for appropriate therapy. Extended-Spectrum beta-Lactamase (ESBL) producing bacteria may not be detected by routine disk diffusion susceptibility test, leading to inappropriate use of antibiotics and treatment failure. The aim of this study was to determine the distribution and antibiotic susceptibility patterns of bacterial strains isolated from patients with community acquired urinary tract infections (UTIs) at Aligarh hospital in India as well as identification of ESBL producers in the population of different uropathogens.MethodsUrinary isolates from symptomatic UTI cases attending to the JN Medical College and hospital at Aligarh were identified by conventional methods. Antimicrobial susceptibility testing was performed by Kirby Bauer's disc diffusion method. Isolates resistant to third generation cephalosporin were tested for ESBL production by double disk synergy test method.ResultsOf the 920 tested sample 100 samples showed growth of pathogens among which the most prevalent were E. coli (61%) followed by Klebsiella spp (22%). The majority (66.66%) of the isolates were from female while the remaining were from male. Among the gram-negative enteric bacilli high prevalence of resistance was observed against ampicillin and co-trimoxazole. Most of the isolates were resistant to 4 or more number of antibiotics. Forty two percent of isolates were detected to produce ESBL among which 34.42 % were E. coli isolates.ConclusionThis study revealed that E. coli was the predominant bacterial pathogen of community acquired UTIs in Aligarh, India. It also demonstrated an increasing resistance to Co-trimoxazole and production of extended spectrum β-lactamase among UTI pathogens in the community. This study is useful for clinician in order to improve the empiric treatment.

[1]  I. Morrissey,et al.  A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection. , 2003, The Journal of infection.

[2]  D. Chinitz,et al.  Empiric Treatment of Uncomplicated Urinary Tract Infection with Fluoroquinolones in Older Women in Israel: Another Lost Treatment Option? , 2006, The Annals of pharmacotherapy.

[3]  A. Schaeffer The expanding role of fluoroquinolones. , 2002, Disease-a-month : DM.

[4]  C. Brun-Buisson,et al.  The Postoperative Bacteriuria Score A New Way to Predict Nosocomial Infection After Prostate Surgery , 2006, Infection Control & Hospital Epidemiology.

[5]  R. Raz,et al.  Antimicrobial susceptibility of community-acquired uropathogens in northern Israel. , 2007, International journal of antimicrobial agents.

[6]  A. J. van der Ven,et al.  Antimicrobial resistance patterns in urinary isolates from nursing home residents. Fifteen years of data reviewed. , 1999, The Journal of antimicrobial chemotherapy.

[7]  D. Drekonja,et al.  Urinary tract infections. , 2003, Primary care.

[8]  R. Joshi,et al.  Antibiotic resistance pattern in uropathogens. , 2002, Indian journal of medical microbiology.

[9]  Ronald N. Jones,et al.  Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  A. Kapil,et al.  Comparative in vitro activity of beta-lactam/beta-lactamase inhibitor combinations against gram negative bacteria. , 2005, The Indian journal of medical research.

[11]  Amna Musharraf,et al.  Plasmid-mediated multiple antibiotic resistance in Proteus mirabilis isolated from patients with urinary tract infection. , 2004, Medical science monitor : international medical journal of experimental and clinical research.

[12]  G. Mudur Drug resistant cholera in India attributed to antibiotic misuse , 2000, BMJ : British Medical Journal.

[13]  R. Daza,et al.  Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections. , 2001, International journal of antimicrobial agents.

[14]  P. Nabeth,et al.  Distribution and susceptibility of bacterial urinary tract infections in Dakar, Senegal. , 2002, International journal of antimicrobial agents.

[15]  C. Mcnulty,et al.  How should general practitioners investigate suspected urinary tract infection? Variations in laboratory-confirmed bacteriuria in South West England. , 2004, Communicable disease and public health.

[16]  S. Hillier,et al.  How strong is the evidence that antibiotic use is a risk factor for antibiotic-resistant, community-acquired urinary tract infection? , 2002, The Journal of antimicrobial chemotherapy.

[17]  Edet E Udo,et al.  Etiology and Antibiotic Susceptibility Patterns of Community-Acquired Urinary Tract Infections in a Kuwait Hospital , 2004, Medical Principles and Practice.

[18]  P. Lagrange,et al.  Escherichia coli : fréquence de résistance et évolution à divers antibiotiques urinaires dont la fosfomycine en milieu hospitalier (11 816 souches, 1991–1995) , 1996 .

[19]  S. Tankhiwale,et al.  Evaluation of extended spectrum beta lactamase in urinary isolates. , 2004, The Indian journal of medical research.

[20]  M. Peng,et al.  Resistance rates to commonly used antimicrobials among pathogens of both bacteremic and non-bacteremic community-acquired urinary tract infection. , 2004, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[21]  John E. Bennett,et al.  Principles and practice of infectious diseases. Vols 1 and 2. , 1979 .

[22]  A. Schaeffer,et al.  Treatment of urinary tract infection: what's old, what's new, and what works , 1999, World Journal of Urology.

[23]  N. Taneja,et al.  Complicated nosocomial UTI caused by nonfermenters , 2002 .

[24]  P. Cahen,et al.  Quelle sensibilité aux antibiotiques pour les bactéries responsables d'infections urinaires ? Que penser de fosfomycine et nitrofuranes ? , 2006 .

[25]  Ronald N. Jones,et al.  Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against recent clinical isolates from India: a survey of ten medical center laboratories. , 2002, Diagnostic microbiology and infectious disease.

[26]  Meenakshi Sharma,et al.  Phenotypic and genotypic detection of ESBL mediated cephalosporin resistance in Klebsiella pneumoniae: emergence of high resistance against cefepime, the fourth generation cephalosporin. , 2006, The Journal of infection.

[27]  A. Manges,et al.  The changing prevalence of drug-resistant Escherichia coli clonal groups in a community: evidence for community outbreaks of urinary tract infections , 2005, Epidemiology and Infection.

[28]  M. Ferraro Performance standards for antimicrobial susceptibility testing , 2001 .

[29]  F. Goldstein,et al.  Antibiotic Susceptibility of Bacterial Strains Isolated from Patients with Community-Acquired Urinary Tract Infections in France , 2000, European Journal of Clinical Microbiology and Infectious Diseases.

[30]  Jason Beckford-Ball,et al.  Management of suspected bacterial urinary tract infection. , 2006, Nursing times.

[31]  G. Kahlmeter Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO.SENS study. , 2003, International journal of antimicrobial agents.

[32]  Vikram Singh,et al.  Choice of antibiotic for empirical therapy of acute cystitis in a setting of high antimicrobial resistance. , 2006, Indian journal of medical sciences.

[33]  C. Kunin,et al.  Urinary tract infections in females. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  V. Lakshmi,et al.  Occurrence of extended spectrum beta-lactamases among Enterobacteriaceae spp. isolated at a tertiary care institute. , 2006, Indian journal of medical microbiology.

[35]  V. Foltán,et al.  Increased consumption of fluoroquinolones is not associated with resistance in Escherichia coli and Staphylococcus aureus in the community. , 2001, The Journal of antimicrobial chemotherapy.

[36]  Eur J Clin Antibiotic Susceptibility of Bacterial Strains Isolated from Patients with Community-Acquired Urinary Tract Infections in France , 2000 .

[37]  C. Giske,et al.  Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates , 2005, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.